Literature DB >> 9295017

Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10.

C Buelens1, V Verhasselt, D De Groote, K Thielemans, M Goldman, F Willems.   

Abstract

We evaluated the effects of interleukin (IL)-10 on the maturation of human dendritic cells (DC) induced either by lipopolysaccharide (LPS) or CD40 engagement. For this purpose, DC generated by culturing plastic-adherent peripheral blood mononuclear cells for 7 days with granulocyte/macrophage-colony-stimulating factor and IL-4 were incubated for 3 days with either LPS (10 ng/ml) or 3T6 fibroblasts transfected with the gene encoding CD40 ligand, in absence or presence of IL-10. First we found that the membrane expression of CD83, a marker of mature DC, was inhibited by IL-10 when induced by LPS but not by CD40 engagement. Likewise, IL-10 inhibited LPS-induced but not CD40-dependent CD86 (B7.2) up-regulation on DC. Furthermore, IL-10 inhibited the production of IL-8 and tumor necrosis factor-alpha by DC when activated by LPS but not by CD40. In contrast, IL-10 inhibited IL-12 production in both activation systems. We conclude that IL-10 differentially influences LPS-dependent and CD40-dependent pathways of DC maturation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295017     DOI: 10.1002/eji.1830270805

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

Review 1.  Dendritic cells: a link between innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

2.  Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli.

Authors:  R J Rigby; S C Knight; M A Kamm; A J Stagg
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

3.  Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3.

Authors:  Yuko Kawakami; Naoki Inagaki; Shahram Salek-Ardakani; Jiro Kitaura; Hiroyuki Tanaka; Koichi Nagao; Yu Kawakami; Wenbin Xiao; Hiroichi Nagai; Michael Croft; Toshiaki Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

Review 4.  Dendritic cells and tumor microenvironment: a dangerous liaison.

Authors:  Ingo Fricke; Dmitry I Gabrilovich
Journal:  Immunol Invest       Date:  2006       Impact factor: 3.657

5.  CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

Authors:  J X Gao; J Madrenas; W Zeng; M J Cameron; Z Zhang; J J Wang; R Zhong; D Grant
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

6.  Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.

Authors:  G L Dixon; P J Newton; B M Chain; D Katz; S R Andersen; S Wong; P van der Ley; N Klein; R E Callard
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation.

Authors:  Kate Mostoller; Christopher C Norbury; Pooja Jain; Brian Wigdahl
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

8.  Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells.

Authors:  Dianne L Commeren; Peter L Van Soest; Khalil Karimi; Bob Löwenberg; Jan J Cornelissen; Eric Braakman
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 9.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

10.  Effects of cytokine milieu secreted by BCG-treated dendritic cells on allergen-specific Th immune response.

Authors:  Youngil I Koh; Inseon S Choi; Je-Jung Lee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.